CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 711 - 720 of 730
Study Number Lead Group Study Title CIRB Study Status
NWU2015-06-02 CLO-Northwestern University Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial Cancer Prevention and Control CIRB Available to Open
NWU2015-06-03 CLO-Northwestern University Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer Cancer Prevention and Control CIRB Available to Open
NWU2015-06-01 CLO-Northwestern University Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention Cancer Prevention and Control CIRB Available to Open
NWU2014-04-01 CLO-Northwestern University Statin Therapy to Reduce the Risk of Recurrent Pancreatitis Cancer Prevention and Control CIRB Available to Open
NWU2017-09-01 CLO-Northwestern University Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery Cancer Prevention and Control CIRB Available to Open
UAZ2015-05-01 CLO-University of Arizona A prospective, single-arm, open-label, non-randomized, phase IIA trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys Cancer Prevention and Control CIRB Available to Open
UAZ2015-05-02 CLO-University of Arizona M4OC-Prevent: Metformin for Oral Cancer Prevention Cancer Prevention and Control CIRB Available to Open
UAZ2017-09-02 CLO-University of Arizona Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers Cancer Prevention and Control CIRB Available to Open
UWI2015-05-01 CLO-University of Wisconsin Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect Cancer Prevention and Control CIRB Available to Open
UWI2016-07-01 CLO-University of Wisconsin Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment Cancer Prevention and Control CIRB Available to Open
Displaying 711 - 720 of 730